Abstract COVID-19-associated mold infection (CAMI) is defined as development of mold
infections in COVID-19 patients. Co-pathogenesis of viral and fungal infections include the …

Background COVID‐19‐associated pulmonary aspergillosis (CAPA) is a major complication
of critically ill COVID‐19 patients, with a high mortality rate and potentially preventable …

COVID-19-associated pulmonary aspergillosis (CAPA) has had a high incidence. In
addition, it has been associated with prolonged hospital stays, as well as several …

Methods Between January 2020 and May 2021, data of severely to critically ill COVID-19
patients were extracted from seven hospitals of the Catholic Medical Center through a …

Background Efficient diagnosis of patients at high risk for invasive aspergillosis (IA)
improves the outcome of the disease. Lateral flow assay (LFA) is a novel technology and …

Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is an
increasingly recognized complication of COVID-19 and is associated with significant over …

Azole resistance in Aspergillus fumigatus (Af) has become a widespread threat and a major
concern for optimal management of patients with invasive aspergillosis (IA). Combination of …

Fungal lung co-infections associated with COVID-19 may occur in severely ill patients or
those with underlying co-morbidities, and immunosuppression. The most common invasive …

It is now well known that patients with severe COVID-19 are at risk for developing invasive
pulmonary aspergillosis (IPA). Nevertheless, the symptomatology of IPA is often atypical in …

Coronavirus disease 2019 (COVID-19) has been shown to be a favoring factor for
aspergillosis, especially in a severe course requiring admission to the intensive care unit …